English
This article is from Indian Journal of Sexually Transmitted Diseases , volume 31 . Abstract Introduction:: Cryptococcal meningitis is one of the acquired immunodeficiency syndrome defining infections with high mortality. Amphotericin B is the preferred drug for induction therapy. Despite advances in human immunodeficiency virus (HIV) treatment, Antiretroviral Treatment (ART) roll-out programs and availability of amphotericin B, cryptococcal meningitis remains an important cause of mortality in the African and other developing countries. Materials and Methods:: We carried out a prospective observational study to determine the treatment response rate, tolerability and outcome of patients with cryptococcal meningitis in HIV treated with amphotericin B. Descriptive statistic was used to analyze the data. Results:: A total of 27 patients were diagnosed with cryptococcal meningitis during the study period. Headache (96.29%) was the single most common presenting symptom of cryptococcal meningitis in HIV-infected patients, followed by vomiting (77.77%) and fever (66.66%). Cerebrospinal fluid (CSF) routine and microscopic examination was within normal limits in six patients. CSF became ster
Sign in with your free account to read, download EPUBs or listen.
Ebook · Management of cryptococcal meningitis in HIV-infected patients: Experience from western India. · Patel, Atul K., Patel, Ketan K., Ranjan, Rajiv, Shah, Shalin, Patel, Jagdish K. · Internet Archive